Hypopharyngeal Cancer

Search with Google Search with Bing
Information
Disease name
Hypopharyngeal Cancer
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT01312350 Completed Phase 2 Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN) November 2010 December 2018
NCT03934294 Completed N/A Acupuncture Effect on Digestion in Critically Ill Post-Operative Oral and Hypo-pharyngeal Cancer Patients May 15, 2019 March 19, 2021
NCT02113878 Completed Phase 1 Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck September 29, 2014 January 1, 2022
NCT00473564 Completed N/A Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery February 2007 December 2015
NCT01435252 Completed Phase 2 A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab September 19, 2011 October 25, 2017
NCT06039631 Recruiting Phase 2 Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer August 22, 2023 September 1, 2029
NCT02012699 Recruiting Integrated Cancer Repository for Cancer Research November 1, 2013 December 2099
NCT04502641 Recruiting Phase 3 Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial August 1, 2020 August 1, 2025
NCT05375266 Recruiting Immune Biomarker Study for Head and Neck Cancer May 16, 2022 March 31, 2027
NCT05420597 Recruiting Phase 2 Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma April 7, 2021 December 31, 2025
NCT05860335 Recruiting Phase 2 Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer July 1, 2021 June 1, 2025
NCT05894070 Recruiting The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer August 2, 2023 December 2024
NCT04539600 Unknown status Phase 2 Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer November 1, 2020 December 12, 2022
NCT00174096 Unknown status The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma August 2005 July 2006
NCT01516996 Unknown status Phase 2 Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer March 2012 March 2018
NCT00173381 Unknown status The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis August 2004
NCT00302562 Unknown status The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma August 2006 July 2007
NCT03558035 Unknown status Phase 2 New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Carcinoma September 2014 March 2021
NCT01175499 Withdrawn N/A Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract July 2010